According to the report titled ‘Global Novel Vaccine Delivery System Market Size study, by Delivery Mode (intradermal, subcutaneous, intramuscular, and other), by Device (Syringe, Needle-Free, Injection System and other) and Regional Forecasts 2021-2027’, available with Market Study Report, global novel vaccine delivery system market is anticipated to grow substantially during 2021-2027.
 

Government initiatives & investments to support surging immunization programs against various diseases with wider coverage, coupled with development of novel vaccines are propelling the growth of global novel vaccine delivery system market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4006451/
 

As per reliable sources, Hindustan Syringes & Medical Devices Ltd. (HMD) made an announcement on August 2020, stating that it has received an order to supply at least 140 million auto disabled syringes for COVID-19 vaccine from United Nation’s Children Fund (UNICEF).
 

For the unversed, vaccines are provided to immunize people of different age groups against certain diseases or infections throughout their life. Vaccines basically contain weakened or inactive microorganisms, particularly referred to as antigens, which triggers immune response in the body. Novel vaccine delivery system generally comprises of methods, technologies, formulations, and systems to administer active pharmaceutical compounds to achieve therapeutic effect on human or animal body.
 

Though strategic initiatives by industry players will impel the growth graph, increasing cost of safety syringes might impede the market progress in the ensuing years.
 

The classification of global novel vaccine delivery system market based on device includes syringe, injection system, needle-free, and others. On the other hand, by delivery mode, the industry is bifurcated into intradermal, subcutaneous, intramuscular, and others.
 

Speaking of geographical ambit, North America, Europe, Asia-Pacific, and Latin America are considered to understand the industry dynamics. Among these, Asia Pacific market is slated to witness considerable gains during 2021-2027, owing to rapid expansion in healthcare infrastructure, and economic development. Apart from that, Asia Pacific is also considered as one of the most populated regions in the world which has further led to increase in vaccine consumption, thereby boosting the market development. For instance, UNICEF India has reported that more than 9 million immunization programs were held in the country in 2020.
 

Key players operating in worldwide novel vaccine delivery system market are Terumo Medical Corporation, Altaris Capital Partners LLC, PharmaJet, Inc., Gerresheimer AG, Gurnet Point Capital LLC, Carl Zeiss Foundation, Retractable Technologies, Inc., Vaxxas Pty. Ltd., Becton, Dickinson and Company, and Inovio Pharmaceuticals, Inc.